GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
New Light Industries Ltd

New Light Industries MD change: Saurabh Agrawal appointed, Himanshi Sharma resigns

MANAGEMENT ● No Immediate Change MEDIUM RISK
📅 Filed on BSE: 24 Mar 2026, 10:52 AM IST  ·  BSE ID: 9f8d1817-cd44-4fb0-936d-3c5f76f87cef
View Original BSE Filing (PDF)
💡
In Simple Terms
The company replaced its Managing Director and CFO on 23 March 2026, with one executive stepping down and another taking both roles, pending shareholder approval.
🤖 AI Summary
  • Saurabh Agrawal (DIN: 08592095) appointed Managing Director from 23 March 2026 for one year
  • Himanshi Sharma resigned as Managing Director and CFO effective 23 March 2026 close of business
  • Agrawal also appointed Chief Financial Officer from 23 March 2026 under Companies Act provisions
  • All appointments require shareholder approval pursuant to Companies Act 2013 and applicable rules
  • M/s. Sumit Bajaj & Associates re-appointed as Secretarial Auditors for FY2025-26
🔢 Key Numbers - exact figures from BSE filing, not rounded
MD Appointment Tenure
One year
MD Appointment Effective Date
23 March 2026
Outgoing MD Cessation Date
23 March 2026 close of business
🏢 How This Affects the Company
⚙️
Operational Impact
Management continuity established through immediate appointment of new MD and CFO on the same day as outgoing MD's resignation. Dual role consolidation under single executive from 23 March 2026.
⚠️
Risk Impact
Succession transition executed with no stated interim period. New MD appointment tenure limited to one year, requiring shareholder approval within statutory timeframe to formalize role.
👥 What This Means For Shareholders
✅
Action Required
Attend shareholder meeting to approve appointment of Saurabh Agrawal as Managing Director for one-year tenure as required by Companies Act 2013.
👤
Who Is Affected
All shareholders. Appointment effective 23 March 2026 but requires shareholder ratification under section 196 of Companies Act 2013 and Companies (Appointment and Qualification of Directors) Rules 2014.
🔍
Management Signal
Board prioritized immediate operational continuity by appointing new MD/CFO same-day as outgoing MD's resignation, consolidating financial and strategic leadership under single executive.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Shareholder meeting notice and approval outcome for Agrawal's MD appointment confirmation
Q1 FY27 results — track financial performance under new MD/CFO leadership team
Annual Report FY26 — verify Agrawal's experience, qualifications, and remuneration details
MEDIUM RISK New MD's one-year tenure creates medium-term continuity uncertainty. Dual role may strain capacity. Shareholder approval not yet obtained. No disclosed transition plan or prior experience of new MD.
💡 Investor Takeaway
Saurabh Agrawal appointed Managing Director and Chief Financial Officer effective 23 March 2026 for one year, replacing Himanshi Sharma who resigned. Appointments require shareholder approval under Companies Act 2013. Dual role consolidation confirms immediate operational continuity with management transition.
⚖️ Strengths & Concerns

⚠️ Concerns

  • MD appointment limited to one year with shareholder approval condition; no medium-term continuity assurance stated.
  • New MD assumes dual MD and CFO responsibilities immediately; no disclosure of prior experience or qualifications.
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.